Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

BB Rasmussen, K Brøsen - Therapeutic Drug Monitoring, 2000 - journals.lww.com
The selective serotonin reuptake inhibitors (SSRIs) comprise citalopram, fluoxetine,
fluvoxamine, paroxetine, and sertraline and they differ from each other in chemical structure, by …

In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes

TL Nielsen, BB Rasmussen, JP Flinois, P Beaune… - … of Pharmacology and …, 1999 - ASPET
The aim of this study was to evaluate the (3S)-3-hydroxylation and the N-oxidation of
quinidine as biomarkers for cytochrome P-450 (CYP)3A4 activity in human liver microsome …

Cytochrome P450 and therapeutic drug monitoring with respect to clozapine

B Buur-Rasmussen, K Brøsen - European Neuropsychopharmacology, 1999 - Elsevier
Clozapine is an atypical antipsychotic drug that is mainly used for the treatment of refractory
schizophrenia. Clozapine is eliminated by oxidation in the liver, predominantly by …

Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans

BB Rasmussen, K Brøsen - Therapeutic drug monitoring, 1996 - journals.lww.com
Caffeine metabolism via the 3-demethylation pathway is sequentially catalyzed by cytochrome
P4501A2 (CYP1A2), xanthine oxidase, and N-acetyltransferase. The activities of the three …

[HTML][HTML] Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial

E Bosch, J Havelock, FS Martin, BB Rasmussen… - Reproductive …, 2019 - Elsevier
Research question To evaluate the immunogenicity of follitropin delta in repeated ovarian
stimulation. Design Controlled, assessor-blind trial in IVF/intracytoplasmic sperm injection …

Fluvoxamine is a Potent Inhibitor of the Metabolism of Caffeine in vitro

BB Rasmussen, TL Nielsen… - Pharmacology & …, 1998 - Wiley Online Library
The selective serotonin re‐uptake inhibitor, fluvoxamine, is a very potent inhibitor of CYP1A2,
and accordingly causes pharmacokinetic interactions with drugs metabolised by CYP1A2, …

Fluvoxamine inhibits the CYP2C19‐catalyzed bioactivation of chloroguanide

U Jeppesen, BB Rasmussen… - Clinical Pharmacology & …, 1997 - Wiley Online Library
Objective To investigate the interaction between fluvoxamine and chloroguanide (INN,
proguanil) to confirm that fluvoxamine inhibits CYP2C19. Methods The study was carried out with …

Griseofulvin and fluvoxamine interactions with the metabolism of theophylline

BB Rasmussen, U Jeppesen, D Gaist… - Therapeutic drug …, 1997 - journals.lww.com
Theophylline is predominantly metabolized by cytochrome P4501A2 (CYP1A2). A possible
interaction between griseofulvin and theophylline was reported to our laboratory, which led …

Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men

…, LØ Reuther, BB Rasmussen… - Clinical …, 2002 - Wiley Online Library
Objective Our objective was to study the effect of recombinant human growth hormone (rhGH)
on hepatic cytochrome P450 (CYP) activity in 30 healthy elderly men. Methods The study …

Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4

H Madsen, BB Rasmussen… - Clinical Pharmacology & …, 1997 - Wiley Online Library
Objectives To further substantiate the role of CYP1A2 and CYP3A4 for the N‐demethylation
in vivo. At least three different P450s appear to be responsible for the N‐demethylation of …